Skip to main content

Table 4 Hazard ratios for relapse fitted with new TRAb’s 4th versus 1st-3rd quartile and into GREATa

From: Comparison of Five TSH-Receptor Antibody Assays in Graves’ disease: results from an observational pilot study

Assay

Recommended cut-offs by the manufacturer

Level of Q4

HR for assay alone (Q4 vs. Q1–3) (95% CI)

HR for GREAT Class II with new assay (95% CI)

HR for GREAT Class III with new assay (95% CI)

BRAHMS TRAK

≥ 1.80 U/L

≥ 8.10 U/L

3.53 (1.35–9.22)

2.02 (0.64–6.36)

3.11 (0.57–17.07)

IMMULITE TSI

≥ 0.55 U/L

≥ 5.66 U/L

3.12 (1.20–8.12)

3.73 (0.84–16.44)

3.01 (0.27–33.34)

EliA anti-TSH-R

≥ 2.90 U/L

≥ 7.40 U/L

4.52 (1.71–11.99)

2.44 (0.79–7.60)

2.37 (0.26–21.18)

RSR TRAb Fast

≥ 1.00 U/L

≥ 7.21 U/L

4.41 (1.66–11.71)

2.47 (0.80–7.72)

1.96 (0.22–17.62)

RSR-bioassay STIMULATION

≥ 150%

≥ 711%

3.63 (1.39–9.46)

N/A

N/A

  1. aClass I serves as reference